ABBY SCHEELE: Open Payments
NPI 1265125975 · YORK, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$92 in 5 payments from 5 companies in 2025. Trend: 2023 $57 · 2024 $180 · 2025 $92
Food & beverage: $92
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $31 |
| Biogen, Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
Products named: QULIPTA, ZURZUVAE, Rybelsus, CAPLYTA, MOUNJARO.
Industry payments across NE — which companies pay providers there.
